Abstract:Key Points Apoptosis, the cell-death programme that is mediated by proteases called caspases, is essential for tissue homeostasis, and its perturbed regulation underlies many diseases, including cancer. Commitment to apoptosis in response to diverse physiological cues and cytotoxic agents is governed by proteins of the Bcl2 family. Bcl2 and several pro-survival relatives associate with the mitochondrial outer membrane and the endoplasmic reticulum/nuclear membrane and maintain their integrity. Initiation of apoptosis requires not only pro-apoptotic family members such as Bax and Bak that closely resemble Bcl2, but also distant cousins that are related only by the small BH3 protein-interaction domain. The BH3-only proteins are sentinels that detect developmental death cues or intracellular damage. In healthy cells, they are restrained in diverse ways, including sequestration on the cytoskeleton. When unleashed by death signals, they switch off survival function by inserting their BH3 domain into a groove on their pro-survival relatives. Either Bax or Bak is required for apoptosis, but how they are activated or countermanded by Bcl2 remains uncertain. During apoptosis, Bax and Bak oligomerize in the mitochondrial outer membrane and probably breach its integrity, freeing pro-apoptotic proteins such as cytochrome c, which allows activation of caspase-9. The pro-survival Bcl2-like proteins can prevent cytochrome c release, and hence caspase-9 activation. They probably also regulate the activation of several other caspases, independently of mitochondrial damage. Impaired apoptosis is a central step towards neoplasia. Pro-survival Bcl2-like proteins can promote tumorigenesis, and certain pro-apoptotic relatives act as tumour suppressors. Moreover, the expression of family members is affected by other tumorigenic alterations (for example, p53 mutation). Conventional cytotoxic therapy indirectly induces apoptosis, but more effective outcomes should be achieved by direct activation of the apoptotic machinery. Promising approaches include impairing expression of pro-survival Bcl2-like proteins or identifying drugs that mimic the action of BH3-only proteins.

Relationship of BCL-2 family members.apoptosis with pulmonary fibrosis

Apoptosis and Bcl-2 Family Proteins, Taken to Chronic Obstructive Pulmonary Disease.

The Expression of Bcl-xl and Apoptosis in the Epithelial Cells of Pulmonary Fibrosis Rats and Intervention Study of Cucumin

Bcl-2 Family Proteins and Apoptosis

[Physiological Function and Structural Basis of Bcl-2 Family Proteins].

The Relationship Between Cell Apoptosis and Cathepsin B Gene Expression in Pulmonary Fibrosis of Rats

The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update

Bcl‐2 Family in Non‐small Cell Lung Cancer: Its Prognostic and Therapeutic Implications

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.

The Bcl2 family: regulators of the cellular life-or-death switch

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

Bleomycin induced apical-basal polarity loss in alveolar epithelial cell contributes to experimental pulmonary fibrosis

Therapeutic Effects of the Bcl-2 Inhibitor on Bleomycin-induced Pulmonary Fibrosis in Mice

The progress of research on anti-apoptotic protein BFL1/hA1

Bcl-2 Silencing Attenuates Hypoxia-Induced Apoptosis Resistance in Pulmonary Microvascular Endothelial Cells

Role for the Bcl-2 Family Proteins and BH3 Domain in Apoptosis

[Progress in Small-Molecule Inhibitors of Bcl-2 Family Proteins].

The Expression of Bcl-2 and Bax and Its Relationship Between the Apoptosis And/or Proliferation

Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins

Expression of Apoptotic and Antiapoptotic Markers in Epithelial Cells in Idiopathic Pulmonary Fibrosis

Expression of Bcl 2 and Its Relationship to the Apoptosis and Proliferation in Lung Cancer